3. Umbruch 4.4..2005 - Online Pot

22 E. Russo
medical use of cannabis products in the German-speaking area]. Forsch Komplementarmed 6
(suppl 3): 28–36
117 Thompson LS (1972) Cannabis sativa and traditions associated with it. Kentucky Folklore Record
18: 1–4
118 Brady CM, DasGupta R, Dalton C, Wiseman OJ, Berkley KJ, Fowler CJ (2004) An open-label
pilot study of cannabis based extracts for bladder dysfunction in advanced multiple sclerosis.
Multiple Sclerosis 10: 425–433
119 Notcutt W, Price M, Miller R, Newport S, Sansom C, Simmonds S (2002) Medicinal cannabis
extract in chronic pain: (7) Results from long term safety extension study (CBME-SAFEX). J
Cannabis Therapeutics 2: 99–100
120 Ferrari F, Ottani A, Giuliani D (2000) Inhibitory effects of the cannabinoid agonist HU 210 on
rat sexual behaviour. Physiol Behav 69: 547–554
121 Kabelik J, Krejčí Z, Santavy´ F (1960) Cannabis as a medicament. Bull Narc 12: 5–23
122 Blevins RD, Dumic MP (1980) The effect of delta-9-tetrahydrocannabinol on herpes simplex
virus replication. J Gen Virol 49: 427–431
123 Campbell WE, Gammon DW, Smith P, Abrahams M, Purves TD (1997) Composition and antimalarial
activity in vitro of the essential oil of Tetradenia riparia. Planta Med 63: 270–272
124 ElSohly HN, Turner CE, Clark AM, Eisohly MA (1982) Synthesis and antimicrobial activities of
certain cannabichromene and cannabigerol related compounds. J Pharm Sci 71: 1319–1323
125 Carson CF, Riley TV (1995) Antimicrobial activity of the major components of the essential oil
of Melaleuca alternifolia. J Appl Bacteriol 78: 264–269
126 Downs AM, Stafford KA, Coles GC (2000) Monoterpenoids and tetralin as pediculocides. Acta
Derm. Venereology 80: 69–70
127 Enan E (2001) Insecticidal activity of essential oils: octopaminergic sites of action. Comp
Biochem Physiol C Toxicol Pharmacol 130: 325–337
128 Priestley CM, Williamson EM, Wafford KA, Sattelle DB (2003) Thymol, a constituent of thyme
essential oil, is a positive allosteric modulator of human GABA-A receptors and a
homo-oligomeric GABA receptor form Drosophila melanogaster. Brit J Pharmacol 140:
1363–1372
129 McPartland JM, Clarke RC, Watson DP (2000) Hemp diseases and pests: Management and biological
control. CABI, Wallingford, UK
130 Devane WA, Hanusˇ L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum
A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the
cannabinoid receptor. Science 258: 1946–1949
131 Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, Nomikos GG, Carter P,
Bymaster FP, Leese AB, Felder CC (2002) Characterization of a novel endocannabinoid, virodhamine,
with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther 301: 1020–1024